Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Erelzi
Erelzi
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay
EP Vantage
Sat, 04/13/19 - 12:23 pm
Amgen
Enbrel
CymaBay
NASH
Erelzi
seladelpar
Genfit
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Thu, 06/29/17 - 09:43 am
Novartis
biosimilars
Enbrel
Europe
Sandoz
Erelzi
Roche
Rituxan
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Novartis
Enbrel
patents
Erelzi
Amgen
biosimilars
rheumatoid arthritis
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Yahoo/AP
Wed, 08/31/16 - 09:27 am
Novartis
biosimilars
Amgen
Enbrel
rheumatoid arthritis
Erelzi